Some experts analyzed and predicted at the China-ASEAN Forum on Drug Safety held on the 21st that in the next decade, the Chinese pharmaceutical market will maintain rapid growth and it is expected to become the world's second largest pharmaceutical market by 2020.

Lin Jianning, director of the Southern Food and Economic Research Institute of the State Food and Drug Administration, analyzed that China is a big pharmaceutical country. In the past decade, the total pharmaceutical market scale has increased from 157.2 billion yuan in 2000 to 619.4 billion yuan in 2009. At the same time, the total output value of China's seven major pharmaceutical industries maintained rapid growth, from 183.4 billion yuan in 2000 to 1004.8 billion yuan in 2009, with a compound annual growth rate of 20.8%.

He said that due to the rapid growth in demand for drugs due to the advent of an aging society, the increasing demand for chronic diseases and drugs to improve quality of life, the expansion of medical insurance coverage, the increase in the level of medical insurance payments, and the continuous growth of medical and healthcare costs and per capita drug use, China Pharmaceutical consumption demand will usher in a new round of more rapid growth.

He believes that during the "12th Five-Year Plan" period, China's pharmaceutical industry will enter an accelerated development period and structural adjustment period. China will become the world's second largest pharmaceutical market, and innovation will dominate the changes in the competitive landscape.

Lin Jianning also analyzed that if the global economy does not experience a major recession, China's GDP will maintain a steady growth of more than 6%, and the new round of medical reform policies will proceed in an orderly and orderly manner. In the next decade, the compound annual growth rate of China's pharmaceutical industry's total output value is expected to reach 22%, and by the year 2019 it will reach 7381.3 billion yuan.